SUZHOU, China, March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating ...
A pre-specified interim analysis showed dual primary endpoint success, with improved PFS and OS versus physician’s-choice chemotherapy in taxane-progressed advanced TNBC. BL-B01D1-307 was a randomized ...
Pathological complete response at surgery was higher with INT230-6 pre-treatment plus Keynote-522 (5/7; 71.4%) than with Keynote-522 alone (2/6; 33%), with one evaluation pending. Grade ≥3 adverse ...
KILLEEN, Texas — When Shewanna Strickland went in for a routine mammogram in April 2024, just after turning 50, she never imagined the journey that lay ahead. What started as a concerning spot on her ...
KILLEEN, Texas — When Shewanna Strickland went in for a routine mammogram in April 2024, just after turning 50, she never imagined the journey that lay ahead. What started as a concerning spot on her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results